Bi/ond Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
16
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$4.5M
- Investors
-
9
Bi/ond General Information
Description
Developer of a customizable organ-on-chip platform designed to bridge the gap between biology and engineering. The company's platform is well-connected to a microfluidic channel through a porous membrane that accommodates a wide variety of tissue sample types, enabling biologists to have direct access to the cell culture.
Contact Information
Website
www.gobiond.comCorporate Office
- Molengraaffsingel 10
- 2629 JD Delft
- Netherlands
Corporate Office
- Molengraaffsingel 10
- 2629 JD Delft
- Netherlands
Bi/ond Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC | 08-Mar-2022 | $4.5M | Completed | Generating Revenue | ||
| 6. Early Stage VC | 08-Oct-2020 | Completed | Startup | |||
| 5. Grant | 07-May-2019 | Completed | Startup | |||
| 4. Accelerator/Incubator | 02-Mar-2018 | Completed | Startup | |||
| 3. Accelerator/Incubator | 03-Jan-2018 | Completed | Startup | |||
| 2. Grant | 20-Oct-2016 | $111K | Completed | Startup | ||
| 1. Accelerator/Incubator | 01-Jan-2016 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Bi/ond Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Bi/ond Patents
Bi/ond Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20230166251-A1 | All-in-one microchamber for 3d muscular tissues | Pending | 28-Apr-2020 | ||
| JP-2023523782-A | All-in-one microchamber for 3d muscle tissue | Pending | 28-Apr-2020 | ||
| CA-3176907-A1 | All-in-one microchamber for 3d muscular tissues | Pending | 28-Apr-2020 | ||
| EP-4143296-A1 | All-in-one microchamber for 3d muscular tissues | Active | 28-Apr-2020 | ||
| EP-4143296-B1 | All-in-one microchamber for 3d muscular tissues | Active | 28-Apr-2020 | B01L3/502715 |
Bi/ond Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Bi/ond Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Delft Enterprises | Venture Capital | Minority | ||
| FORWARD.one | Venture Capital | Minority | ||
| InnovationQuarter | Venture Capital | Minority | ||
| UNIIQ | Venture Capital | Minority | ||
| Philips Innovation Award | Other |
Bi/ond FAQs
-
When was Bi/ond founded?
Bi/ond was founded in 2016.
-
Where is Bi/ond headquartered?
Bi/ond is headquartered in Delft, Netherlands.
-
What is the size of Bi/ond?
Bi/ond has 16 total employees.
-
What industry is Bi/ond in?
Bi/ond’s primary industry is Other Devices and Supplies.
-
Is Bi/ond a private or public company?
Bi/ond is a Private company.
-
What is Bi/ond’s current revenue?
The current revenue for Bi/ond is .
-
How much funding has Bi/ond raised over time?
Bi/ond has raised $4.79M.
-
Who are Bi/ond’s investors?
Delft Enterprises, FORWARD.one, InnovationQuarter, UNIIQ, and Philips Innovation Award are 5 of 9 investors who have invested in Bi/ond.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
